Lexicon Q2 FY26 net loss widens to $31.8 million; revenue drops to $0.7 million

Reuters2026/08/06 11:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Lexicon posted Q2 2026 revenue of $0.7 million, down 97.58% from a year earlier.
Net loss widened to $31.8 million, or $0.07 per share, swinging from net income of $3.3 million, or $0.01 per share.
R&D expenses rose to $17.4 million; SG&A expenses increased to $9.8 million.
Cash and investments totaled $190.6 million at June 30, 2026; it also put in place a $100 million Hercules Capital loan facility.
Enrollment finished in the Phase 3 SONATA-HCM trial with top-line data expected in Q1 2027; ZYNQUISTA NDA resubmission targeted for Q4 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062822-26-000112), on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Lexicon Q2 FY26 net loss widens to $31.8 million; revenue drops to $0.7 million

You may also like

Crypto prices